Further work, ideally in the form of randomised-controlled trials, is necessary to determine whether removal of the ovaries, uterus or both is the optimal strategy for symptom control in patients with severe endometriosis, as well as the role of GnRH analogues post-surgery. This evidence concerns the gene GNRH1 and endometriosis.